These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16959487)

  • 1. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
    Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
    Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
    Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
    Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator.
    Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P
    J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
    J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold.
    Ng RA; Lanter JC; Alford VC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1784-7. PubMed ID: 17197181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.
    Manfredi MC; Bi Y; Nirschl AA; Sutton JC; Seethala R; Golla R; Beehler BC; Sleph PG; Grover GJ; Ostrowski J; Hamann LG
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4487-90. PubMed ID: 17574413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 1.
    Charton J; Cazenave Gassiot A; Girault-Mizzi S; Debreu-Fontaine MA; Melnyk P; Sergheraert C
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4833-7. PubMed ID: 16140011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.
    Balog A; Salvati ME; Shan W; Mathur A; Leith LW; Wei DD; Attar RM; Geng J; Rizzo CA; Wang C; Krystek SR; Tokarski JS; Hunt JT; Gottardis M; Weinmann R
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6107-11. PubMed ID: 15546739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
    Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 2.
    Cazenave Gassiot A; Charton J; Girault-Mizzi S; Gilleron P; Debreu-Fontaine MA; Sergheraert C; Melnyk P
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4828-32. PubMed ID: 16140009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.
    van Oeveren A; Motamedi M; Mani NS; Marschke KB; López FJ; Schrader WT; Negro-Vilar A; Zhi L
    J Med Chem; 2006 Oct; 49(21):6143-6. PubMed ID: 17034117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs).
    Miller CP; Bhaket P; Muthukaman N; Lyttle CR; Shomali M; Gallacher K; Slocum C; Hattersley G
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7516-20. PubMed ID: 21036041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.